Note1

From NAMIC Wiki
Revision as of 13:33, 18 December 2006 by Andy (talk | contribs) (Update from Wiki)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Home < Note1

Could a single library be used both for prototyping and commercial product development?

How can commercial party get benefit by providing softaware API to IGT research community?

  • Sharing research resource with research community
  • Accessing talent and idea outside of company.
  • IP is an issue (enable others to develop competing IP is bad)
  • Support cost for companies is also an issue
  • Solution ideas: need to make it an issue of "compliance" and need to get clinicians to request it

How can IGT be science?

  • Technologies being pushed by IGT
    • Validation
    • Integration
    • Workflow

--User:Hata 13:52, 19 October 2006 (EDT) (and Stephen :) )

Retrieved from "https://www.na-mic.org/w/index.php?title=Note1&oldid=3979"